Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1/2 2Phase 1 2Phase NA 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1CNS 1

Conditions

Optic Nerve Glioma 1Neoplasms, Unknown Primary 1Gliosarcoma 1Glioma 1Glioblastoma 1Gastrointestinal Neoplasms 1Diffuse Intrinsic Pontine Glioma 1Astrocytoma 1

Interventions

pembrolizumab 410Cyclophosphamide 394Carboplatin 306Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 210Bevacizumab 209fludarabine 192Docetaxel 187Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 120Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Interventional × Mebendazole × Clear all
NCT01837862 2024-07-05

A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas

Northwell Health

Phase 1/2 Completed
36 enrolled
CNSSarcoma

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Glioblastoma, Glioma, Gliosarcoma, Optic Nerve Glioma

NCT03628079 2020-01-22

RepoMeb

Repos Pharma

Phase 1/2 Terminated
11 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡